Shattuck Labs enlisted XVIVO to develop a mechanism of action animation for their ARC platform (or Agonist Redirected Checkpoint), which links checkpoint blockade and immune co-stimulation in a single molecule, to treat cancer.
KV7 MOA Animation
By
Jordan Maire
Biohaven Pharmaceuticals and XVIVO teamed up again, this time to create a mechanism of action animation for BHV-7000, their recently-acquired Kv7 activator. The BHV-7000 molecule blocks the action of the voltage-gated Kv7 potassium ion channel, which exquisitely regulates the excitability of neurons in the central nervous system.
Soliris MOA Animation
By
Jordan Maire
With Alexion Pharmaceuticals, we created a Soliris mechanism of action animation for the treatment of Myasthenia Gravis (MG). MG is an autoimmune disorder characterized by neuromuscular transmission failure and subsequent voluntary muscle weakness.
Predator Platform Technology Animation
By
Jordan Maire
XVIVO recently partnered with Werewolf Therapeutics to create an animation about their INDUKINE molecules and how the molecules could transform immunotherapy as it is practiced today.
Listerine MOA Animation
By
Jordan Maire
The most recent program we developed for Listerine detailed the MOA of Listerine and presented exciting new data on how Listerine reduced plaque buildup compared to flossing.
Oxidative Damage in Red Blood Cells MOA Animation
By
Jordan Maire
Working closely with the Hemanext team, we crafted medical animations to elucidate the science behind oxidative damage in stored blood. To leverage the visuals for multiple communication needs, the content was broken into chapters.
Anchored Immunotherapy MOA Animation
By
Jordan Maire
Ankyra Therapeutics teamed up with XVIVO on a scientific animation touting their anchored immunotherapy approach to cancer treatment, which is designed to promote prolonged immune activation at the tumor site while limiting systemic toxicity that can be associated with other immunotherapy.
The Role Of PKR Activation In Sickle Cell Disease MOA Animation
By
Jordan Maire
XVIVO and Forma partnered together for multiple medical animation projects to educate both healthcare professionals and patients on their scientific approach. Sickle cell disease is an inherited genetic disease that has serious impacts on the people living with it. Forma Therapeutics is fiercely dedicated to improving the lives of these patients.
Ociperlimab MOA
By
Jordan Maire
Designed by BeiGene, Ociperlimab is an investigational monoclonal antibody designed to bind to TIGIT in an effort to combat cancer. Together with BeiGene we created an animation to support their groundbreaking work.
Vividion Targeted Protein Therapeutic Animation
By
Jordan Maire
XVIVO had the pleasure of working with Vividion Therapeutics on a 3D medical animation for their covalent molecule platform.
Shattuck Labs enlisted XVIVO to develop a mechanism of action animation for their ARC platform (or Agonist Redirected Checkpoint), which links checkpoint blockade and immune co-stimulation in a single molecule, to treat cancer.
